m 6 A Modification Prevents Formation of Endogenous Double-Stranded RNAs and Deleterious Innate Immune Responses during Hematopoietic Development

N -methyladenosine (m A) is the most abundant RNA modification, but little is known about its role in mammalian hematopoietic development. Here, we show that conditional deletion of the m A writer METTL3 in murine fetal liver resulted in hematopoietic failure and perinatal lethality. Loss of METTL3...

Full description

Saved in:
Bibliographic Details
Published inImmunity (Cambridge, Mass.) Vol. 52; no. 6; p. 1007
Main Authors Gao, Yimeng, Vasic, Radovan, Song, Yuanbin, Teng, Rhea, Liu, Chengyang, Gbyli, Rana, Biancon, Giulia, Nelakanti, Raman, Lobben, Kirsten, Kudo, Eriko, Liu, Wei, Ardasheva, Anastasia, Fu, Xiaoying, Wang, Xiaman, Joshi, Poorval, Lee, Veronica, Dura, Burak, Viero, Gabriella, Iwasaki, Akiko, Fan, Rong, Xiao, Andrew, Flavell, Richard A, Li, Hua-Bing, Tebaldi, Toma, Halene, Stephanie
Format Journal Article
LanguageEnglish
Published United States Elsevier Limited 16.06.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract N -methyladenosine (m A) is the most abundant RNA modification, but little is known about its role in mammalian hematopoietic development. Here, we show that conditional deletion of the m A writer METTL3 in murine fetal liver resulted in hematopoietic failure and perinatal lethality. Loss of METTL3 and m A activated an aberrant innate immune response, mediated by the formation of endogenous double-stranded RNAs (dsRNAs). The aberrantly formed dsRNAs were long, highly m A modified in their native state, characterized by low folding energies, and predominantly protein coding. We identified coinciding activation of pattern recognition receptor pathways normally tasked with the detection of foreign dsRNAs. Disruption of the aberrant immune response via abrogation of downstream Mavs or Rnasel signaling partially rescued the observed hematopoietic defects in METTL3-deficient cells in vitro and in vivo. Our results suggest that m A modification protects against endogenous dsRNA formation and a deleterious innate immune response during mammalian hematopoietic development.
AbstractList SummaryN6-methyladenosine (m6A) is the most abundant RNA modification, but little is known about its role in mammalian hematopoietic development. Here, we show that conditional deletion of the m6A writer METTL3 in murine fetal liver resulted in hematopoietic failure and perinatal lethality. Loss of METTL3 and m6A activated an aberrant innate immune response, mediated by the formation of endogenous double-stranded RNAs (dsRNAs). The aberrantly formed dsRNAs were long, highly m6A modified in their native state, characterized by low folding energies, and predominantly protein coding. We identified coinciding activation of pattern recognition receptor pathways normally tasked with the detection of foreign dsRNAs. Disruption of the aberrant immune response via abrogation of downstream Mavs or Rnasel signaling partially rescued the observed hematopoietic defects in METTL3-deficient cells in vitro and in vivo. Our results suggest that m6A modification protects against endogenous dsRNA formation and a deleterious innate immune response during mammalian hematopoietic development.
N -methyladenosine (m A) is the most abundant RNA modification, but little is known about its role in mammalian hematopoietic development. Here, we show that conditional deletion of the m A writer METTL3 in murine fetal liver resulted in hematopoietic failure and perinatal lethality. Loss of METTL3 and m A activated an aberrant innate immune response, mediated by the formation of endogenous double-stranded RNAs (dsRNAs). The aberrantly formed dsRNAs were long, highly m A modified in their native state, characterized by low folding energies, and predominantly protein coding. We identified coinciding activation of pattern recognition receptor pathways normally tasked with the detection of foreign dsRNAs. Disruption of the aberrant immune response via abrogation of downstream Mavs or Rnasel signaling partially rescued the observed hematopoietic defects in METTL3-deficient cells in vitro and in vivo. Our results suggest that m A modification protects against endogenous dsRNA formation and a deleterious innate immune response during mammalian hematopoietic development.
Author Xiao, Andrew
Song, Yuanbin
Joshi, Poorval
Biancon, Giulia
Fan, Rong
Teng, Rhea
Dura, Burak
Liu, Chengyang
Fu, Xiaoying
Gbyli, Rana
Iwasaki, Akiko
Liu, Wei
Flavell, Richard A
Ardasheva, Anastasia
Gao, Yimeng
Kudo, Eriko
Li, Hua-Bing
Lee, Veronica
Viero, Gabriella
Tebaldi, Toma
Vasic, Radovan
Lobben, Kirsten
Wang, Xiaman
Halene, Stephanie
Nelakanti, Raman
Author_xml – sequence: 1
  givenname: Yimeng
  surname: Gao
  fullname: Gao, Yimeng
  email: yimeng.gao@yale.edu
  organization: Section of Hematology, Yale Cancer Center and Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA; Yale Stem Cell Center and Yale RNA Center, Yale University School of Medicine, New Haven, CT 06520, USA. Electronic address: yimeng.gao@yale.edu
– sequence: 2
  givenname: Radovan
  surname: Vasic
  fullname: Vasic, Radovan
  organization: Section of Hematology, Yale Cancer Center and Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA; Yale Stem Cell Center and Yale RNA Center, Yale University School of Medicine, New Haven, CT 06520, USA
– sequence: 3
  givenname: Yuanbin
  surname: Song
  fullname: Song, Yuanbin
  organization: Section of Hematology, Yale Cancer Center and Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA; Yale Stem Cell Center and Yale RNA Center, Yale University School of Medicine, New Haven, CT 06520, USA
– sequence: 4
  givenname: Rhea
  surname: Teng
  fullname: Teng, Rhea
  organization: Section of Hematology, Yale Cancer Center and Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA; Yale Stem Cell Center and Yale RNA Center, Yale University School of Medicine, New Haven, CT 06520, USA
– sequence: 5
  givenname: Chengyang
  surname: Liu
  fullname: Liu, Chengyang
  organization: Section of Hematology, Yale Cancer Center and Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA; Yale Stem Cell Center and Yale RNA Center, Yale University School of Medicine, New Haven, CT 06520, USA
– sequence: 6
  givenname: Rana
  surname: Gbyli
  fullname: Gbyli, Rana
  organization: Section of Hematology, Yale Cancer Center and Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA; Yale Stem Cell Center and Yale RNA Center, Yale University School of Medicine, New Haven, CT 06520, USA
– sequence: 7
  givenname: Giulia
  surname: Biancon
  fullname: Biancon, Giulia
  organization: Section of Hematology, Yale Cancer Center and Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA; Yale Stem Cell Center and Yale RNA Center, Yale University School of Medicine, New Haven, CT 06520, USA
– sequence: 8
  givenname: Raman
  surname: Nelakanti
  fullname: Nelakanti, Raman
  organization: Department of Genetics and Yale Stem Cell Center, Yale University School of Medicine, New Haven, CT 06520, USA
– sequence: 9
  givenname: Kirsten
  surname: Lobben
  fullname: Lobben, Kirsten
  organization: Section of Hematology, Yale Cancer Center and Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA; Yale Stem Cell Center and Yale RNA Center, Yale University School of Medicine, New Haven, CT 06520, USA
– sequence: 10
  givenname: Eriko
  surname: Kudo
  fullname: Kudo, Eriko
  organization: Department of Molecular Cellular and Developmental Biology, Yale University, New Haven, CT 06520, USA; Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA
– sequence: 11
  givenname: Wei
  surname: Liu
  fullname: Liu, Wei
  organization: Section of Hematology, Yale Cancer Center and Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA; Yale Stem Cell Center and Yale RNA Center, Yale University School of Medicine, New Haven, CT 06520, USA
– sequence: 12
  givenname: Anastasia
  surname: Ardasheva
  fullname: Ardasheva, Anastasia
  organization: Section of Hematology, Yale Cancer Center and Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA; Yale Stem Cell Center and Yale RNA Center, Yale University School of Medicine, New Haven, CT 06520, USA
– sequence: 13
  givenname: Xiaoying
  surname: Fu
  fullname: Fu, Xiaoying
  organization: Section of Hematology, Yale Cancer Center and Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA; Yale Stem Cell Center and Yale RNA Center, Yale University School of Medicine, New Haven, CT 06520, USA
– sequence: 14
  givenname: Xiaman
  surname: Wang
  fullname: Wang, Xiaman
  organization: Section of Hematology, Yale Cancer Center and Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA; Yale Stem Cell Center and Yale RNA Center, Yale University School of Medicine, New Haven, CT 06520, USA
– sequence: 15
  givenname: Poorval
  surname: Joshi
  fullname: Joshi, Poorval
  organization: Section of Hematology, Yale Cancer Center and Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA; Yale Stem Cell Center and Yale RNA Center, Yale University School of Medicine, New Haven, CT 06520, USA
– sequence: 16
  givenname: Veronica
  surname: Lee
  fullname: Lee, Veronica
  organization: Section of Hematology, Yale Cancer Center and Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA; Yale Stem Cell Center and Yale RNA Center, Yale University School of Medicine, New Haven, CT 06520, USA
– sequence: 17
  givenname: Burak
  surname: Dura
  fullname: Dura, Burak
  organization: Yale Stem Cell Center and Yale RNA Center, Yale University School of Medicine, New Haven, CT 06520, USA; Department of Biomedical Engineering and Yale Cancer Center, Yale University, New Haven, CT 06520, USA
– sequence: 18
  givenname: Gabriella
  surname: Viero
  fullname: Viero, Gabriella
  organization: Institute of Biophysics, CNR Unit at Trento, Povo Trento 38123, Italy
– sequence: 19
  givenname: Akiko
  surname: Iwasaki
  fullname: Iwasaki, Akiko
  organization: Department of Molecular Cellular and Developmental Biology, Yale University, New Haven, CT 06520, USA; Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA
– sequence: 20
  givenname: Rong
  surname: Fan
  fullname: Fan, Rong
  organization: Yale Stem Cell Center and Yale RNA Center, Yale University School of Medicine, New Haven, CT 06520, USA; Department of Biomedical Engineering and Yale Cancer Center, Yale University, New Haven, CT 06520, USA
– sequence: 21
  givenname: Andrew
  surname: Xiao
  fullname: Xiao, Andrew
  organization: Department of Genetics and Yale Stem Cell Center, Yale University School of Medicine, New Haven, CT 06520, USA
– sequence: 22
  givenname: Richard A
  surname: Flavell
  fullname: Flavell, Richard A
  email: richard.flavell@yale.edu
  organization: Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA. Electronic address: richard.flavell@yale.edu
– sequence: 23
  givenname: Hua-Bing
  surname: Li
  fullname: Li, Hua-Bing
  email: huabing.li@shsmu.edu.cn
  organization: Shanghai Institute of Immunology, State Key Laboratory of Oncogenes and Related Genes, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China; Shanghai Jiao Tong University School of Medicine-Yale Institute for Immune Metabolism, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China. Electronic address: huabing.li@shsmu.edu.cn
– sequence: 24
  givenname: Toma
  surname: Tebaldi
  fullname: Tebaldi, Toma
  email: toma.tebaldi@yale.edu
  organization: Section of Hematology, Yale Cancer Center and Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA; Yale Stem Cell Center and Yale RNA Center, Yale University School of Medicine, New Haven, CT 06520, USA. Electronic address: toma.tebaldi@yale.edu
– sequence: 25
  givenname: Stephanie
  surname: Halene
  fullname: Halene, Stephanie
  email: stephanie.halene@yale.edu
  organization: Section of Hematology, Yale Cancer Center and Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA; Yale Stem Cell Center and Yale RNA Center, Yale University School of Medicine, New Haven, CT 06520, USA. Electronic address: stephanie.halene@yale.edu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32497523$$D View this record in MEDLINE/PubMed
BookMark eNo1kNlqwzAQRUVJaZb2D0oR9NmuNm-PIUsTSBfSvBvbGgcFW3IlO9DP6B_XJunTXC5n7h1mikbaaEDokRKfEhq-nHxV151WPiOM-CTwCeE3aEJJEnmCxmQ06Eh4UUj5GE2dOxFCRZCQOzTmTCRRwPgE_dY4xHP8ZqQqVZG1ymj8aeEMunV4bWx9sUyJV1qaI2jTObw0XV6B99XaTEuQeP8-d7iXeAkVtGDVAG21zlrA2-FIwHtwjdEOHJadVfqIN9BHm8YoaFXRL56hMk3d196j2zKrHDxc5wwd1qvDYuPtPl63i_nOawLKvTwCSvIg43nJAWJZggxZEQ5GHkIRi5iJsCiYLICzSMZZLkomKCFxkZRJQvkMPV9iG2u-O3BtejKd1X1jygQLwphHgvTU05Xq8hpk2lhVZ_Yn_X8g_wPYu3i8
ContentType Journal Article
Copyright Copyright © 2020 Elsevier Inc. All rights reserved.
2020. Elsevier Inc.
Copyright_xml – notice: Copyright © 2020 Elsevier Inc. All rights reserved.
– notice: 2020. Elsevier Inc.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7QL
7QP
7QR
7T5
7T7
7TK
7TM
7U9
8FD
C1K
FR3
H94
K9.
M7N
NAPCQ
P64
RC3
DOI 10.1016/j.immuni.2020.05.003
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Immunology Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Neurosciences Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Nursing & Allied Health Premium
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Virology and AIDS Abstracts
Technology Research Database
Nucleic Acids Abstracts
ProQuest Health & Medical Complete (Alumni)
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
Nursing & Allied Health Premium
Genetics Abstracts
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
Chemoreception Abstracts
Immunology Abstracts
Engineering Research Database
Industrial and Applied Microbiology Abstracts (Microbiology A)
Calcium & Calcified Tissue Abstracts
DatabaseTitleList Virology and AIDS Abstracts
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1097-4180
ExternalDocumentID 32497523
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIDDK NIH HHS
  grantid: U54 DK106857
– fundername: NCATS NIH HHS
  grantid: UL1 TR001863
– fundername: NIDDK NIH HHS
  grantid: R01 DK102792
– fundername: NIGMS NIH HHS
  grantid: T32 GM007205
– fundername: NCI NIH HHS
  grantid: R01 CA222518
GroupedDBID ---
--K
-DZ
0R~
1RT
1~5
2WC
4.4
457
4G.
53G
5GY
62-
7-5
8FE
8FH
AACTN
AAEDT
AAEDW
AAKRW
AALRI
AAMRU
AAVLU
AAXUO
ABMAC
ABOCM
ACGFO
ACGFS
ACIWK
ACPRK
ADBBV
ADEZE
ADFRT
ADVLN
AEFWE
AENEX
AEXQZ
AFRAH
AFTJW
AGGSO
AGKMS
AHMBA
AITUG
AKAPO
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ASPBG
AVWKF
AZFZN
BAWUL
BKEYQ
BPHCQ
BVXVI
C45
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EBS
ECM
EIF
EJD
F5P
FCP
FDB
FIRID
IH2
IHE
IXB
J1W
JIG
LK8
LX5
M3Z
M41
N9A
NPM
O-L
O9-
OK1
OVD
P2P
PQQKQ
PROAC
ROL
RPZ
SCP
SES
SSZ
TEORI
TR2
7QL
7QP
7QR
7T5
7T7
7TK
7TM
7U9
8FD
AAYWO
ABDGV
ABJNI
ACVFH
ADCNI
AEUPX
AFPUW
AGCQF
AIGII
AKBMS
AKYEP
APXCP
C1K
EFKBS
FR3
H94
K9.
M7N
NAPCQ
P64
RC3
ID FETCH-LOGICAL-p513-b7e10b5a3bf3ee8dfed62c65a3bb6ec848246cc2dce327d8ab4f241008c9f9913
ISSN 1074-7613
IngestDate Fri Jul 25 11:13:01 EDT 2025
Thu Apr 03 06:52:28 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords dsRNA
RNA modification
hematopoietic development
N-methyladenosine
hematopoiesis
innate immune response
METTL3
m6A
epitranscriptome
double-stranded RNA
Language English
License Copyright © 2020 Elsevier Inc. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-p513-b7e10b5a3bf3ee8dfed62c65a3bb6ec848246cc2dce327d8ab4f241008c9f9913
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
PMID 32497523
PQID 2425683740
PQPubID 2031079
ParticipantIDs proquest_journals_2425683740
pubmed_primary_32497523
PublicationCentury 2000
PublicationDate 2020-06-16
20200616
PublicationDateYYYYMMDD 2020-06-16
PublicationDate_xml – month: 06
  year: 2020
  text: 2020-06-16
  day: 16
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Cambridge
PublicationTitle Immunity (Cambridge, Mass.)
PublicationTitleAlternate Immunity
PublicationYear 2020
Publisher Elsevier Limited
Publisher_xml – name: Elsevier Limited
SSID ssj0014590
Score 2.3283796
Snippet N -methyladenosine (m A) is the most abundant RNA modification, but little is known about its role in mammalian hematopoietic development. Here, we show that...
SummaryN6-methyladenosine (m6A) is the most abundant RNA modification, but little is known about its role in mammalian hematopoietic development. Here, we show...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 1007
SubjectTerms Adenosine - chemistry
Animals
Biomarkers
Bone marrow
Bone Marrow Failure Disorders - etiology
Bone Marrow Failure Disorders - metabolism
Bone Marrow Failure Disorders - pathology
Cell Differentiation - genetics
Defects
Disease Models, Animal
Double-stranded RNA
Epigenesis, Genetic
Fetuses
Gene Expression
Genes
Hematopoiesis - genetics
Hematopoiesis - immunology
Hematopoietic Stem Cells
Immune response
Immune system
Immunity, Innate - genetics
Immunophenotyping
Innate immunity
Lethality
Leukemia
Liver
Liver diseases
Mammals
Methylation
Methyltransferases - genetics
Methyltransferases - metabolism
Mice
Mice, Knockout
N6-methyladenosine
Pattern recognition
Pattern recognition receptors
Protein folding
RNA modification
RNA, Double-Stranded - chemistry
RNA, Double-Stranded - metabolism
Stem cells
Title m 6 A Modification Prevents Formation of Endogenous Double-Stranded RNAs and Deleterious Innate Immune Responses during Hematopoietic Development
URI https://www.ncbi.nlm.nih.gov/pubmed/32497523
https://www.proquest.com/docview/2425683740
Volume 52
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nj9MwELVKVyAuCJavhQX5wK1K1DiOkxwrtKXLbotUstA9RXHioKLdpCItEvwLfgl_kRk7X7ALAi5RNJLbyPMSz4zf8xDyAre-RJggp8qHBCWTgSWZz6wsAasThNLRKv75QszO-OuVtxoMvvdYS7uttNOv1-pK_serYAO_okr2Hzzb_igY4B78C1fwMFz_yseXIwEv9rzMkO9jPFkfyVSNpo0qUXMHi6ysT2OFiFleKAtPpcXi92i5mFQ1H_kCqTGaE3tcFBCDjo5RPIKNHTSPVlWNqHGGB72Wm3KNCsg-76gf6urBGOPjPnGjDDPyoKqyexWIV4ku155jn4EPjfFdAvDR_k-y8nMH4bc1hfh8lxRy3bGIlTEvYW3pFzIY9ruxjM7SVNcahc0VZZfhjAqjWbVVbQt9izumC1TzJfdYD7H9zzJSQa5dL0zp4qO91lNi42Ppg1zHbrc-NpyAxZt4enZ6GkdHq-gG2WOQl7Ah2ZucLN-ftBtX3AvHLc0VHrlRa2pK4dV_-X1eo-Ob6C65UycmdGJQdo8MVLFPbppWpV_2ya15TcK4T75dUkEntA872sCOtrCjZU472NFfYEcRdhRuaQ921MCOGtjRFnbUwI7-BDvag90DEk2Popczq-7sYW08x7Wkr5yx9BJX5q5SQZarTLBUoEEKlQY8YBz5_FmqXOZnQSJ5DpEmhKtpmENC4z4kw6Is1GNCPZb4jiO9TMiA43YhTz2X41jmKi68A3LYTHBcv7lVjGm2CFyfjw_IIzPp8cYc7hJDghH6HnOf_HngU3K7w_AhGW4_7dQzCE-38nkNiR8zfpS6
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=m+6+A+Modification+Prevents+Formation+of+Endogenous+Double-Stranded+RNAs+and+Deleterious+Innate+Immune+Responses+during+Hematopoietic+Development&rft.jtitle=Immunity+%28Cambridge%2C+Mass.%29&rft.au=Gao%2C+Yimeng&rft.au=Vasic%2C+Radovan&rft.au=Song%2C+Yuanbin&rft.au=Teng%2C+Rhea&rft.date=2020-06-16&rft.pub=Elsevier+Limited&rft.issn=1074-7613&rft.eissn=1097-4180&rft.volume=52&rft.issue=6&rft.spage=1007&rft_id=info:doi/10.1016%2Fj.immuni.2020.05.003&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1074-7613&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1074-7613&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1074-7613&client=summon